 Home > Medical News > Latest Medical News > Yiling Pharmaceutical: Lianhua Qingwen Capsules Obtained Ukrainian Drug Registration Approval

Yiling Pharmaceutical: Lianhua Qingwen Capsules Obtained Ukrainian Drug Registration Approval

 Last Update: 2021-08-30
 Source: Internet
 Author: User

Tags

naproxen drug class

hershey products list

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 28, Yiling Pharmaceutical announced that Lianhua Qingwen Capsules had obtained Ukrainian drug registration approval

Lianhua Qingwen products are the company’s leading products, the National Essential Drug List and the National Medical Insurance List (Class A), and are mainly used for the treatment of colds and flu-related diseases

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.